p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α–mediated down-regulation of CXCL12

Fms-like tyrosine kinase-3 (FLT3) inhibitors have been used to overcome the dismal prognosis of acute myeloid leukemia (AML) with FLT3 mutations. Clinical results with FLT3 inhibitor monotherapy have shown that bone marrow responses are commonly less pronounced than peripheral blood responses. We in...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kojima, Kensuke, McQueen, Teresa, Chen, Ye, Jacamo, Rodrigo, Konopleva, Marina, Shinojima, Naoki, Shpall, Elizabeth, Huang, Xuelin, Andreeff, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2011
Témata:
Myeloid Neoplasia
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3204912/
https://ncbi.nlm.nih.gov/pubmed/21868571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-02-334136
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky